{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:01:18Z","timestamp":1791896478035,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1124\/jpet.110.170555","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T03:03:40Z","timestamp":1282878220000},"page":"715-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc\/Max Dimerization"],"prefix":"10.1016","volume":"335","author":[{"given":"Dana M.","family":"Clausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Parise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Beumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill J.","family":"Egorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Lazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Prochownik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Eiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.170555_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/MCB.21.3.691-702.2001","article-title":"The Max network gone mad","volume":"21","author":"Baudino","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.110.170555_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cbpa.2008.07.023","article-title":"Inhibition of transcription factors with small organic molecules","volume":"12","author":"Berg","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/jpet.110.170555_bib3","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1073\/pnas.062036999","article-title":"Small-molecule antagonists of Myc\/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts","volume":"99","author":"Berg","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.110.170555_bib4","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations involving c-myc and c-myc function","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene"},{"key":"10.1124\/jpet.110.170555_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological parameter values for physiologically based pharmacokinetic models","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol Ind Health"},{"key":"10.1124\/jpet.110.170555_bib6","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.110.170555_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.19.1.1","article-title":"c-Myc target genes involved in cell growth, apoptosis, and metabolism","volume":"19","author":"Dang","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.110.170555_bib8","series-title":"ADAPT II User\u2019s Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software","year":"1997"},{"key":"10.1124\/jpet.110.170555_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1097-2765(00)80367-6","article-title":"Reversible tumorigenesis by MYC in hematopoietic lineages","volume":"4","author":"Felsher","year":"1999","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.110.170555_bib10","first-page":"1535","article-title":"Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia","volume":"46","author":"Fleming","year":"1986","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.110.170555_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bmcl.2008.12.025","article-title":"Small-molecule perturbation of competing interactions between c-Myc and Max","volume":"19","author":"Follis","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.110.170555_bib12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.chembiol.2008.09.011","article-title":"Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules","volume":"15","author":"Follis","year":"2008","journal-title":"Chem Biol"},{"key":"10.1124\/jpet.110.170555_bib13","series-title":"Encyclopedia of Cancer","first-page":"555","article-title":"c-myc protooncogene","author":"Gardner","year":"2002"},{"key":"10.1124\/jpet.110.170555_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpedsurg.2005.10.025","article-title":"c-Myc inhibition negatively impacts lymphoma growth","volume":"41","author":"Gomez-Curet","year":"2006","journal-title":"J Pediatr Surg"},{"key":"10.1124\/jpet.110.170555_bib15","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1128\/MCB.20.7.2423-2435.2000","article-title":"c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt\u2019s lymphoma cells","volume":"20","author":"Gregory","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.110.170555_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00280-008-0774-y","article-title":"Efficacy, pharmacokinetics, tissue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice","volume":"63","author":"Guo","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/jpet.110.170555_bib17","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1021\/ja900616b","article-title":"Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc","volume":"131","author":"Hammoudeh","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.110.170555_bib18","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.exphem.2006.06.019","article-title":"A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia","volume":"34","author":"Huang","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1124\/jpet.110.170555_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1071489","article-title":"Sustained loss of a neoplastic phenotype by brief inactivation of MYC","volume":"297","author":"Jain","year":"2002","journal-title":"Science"},{"key":"10.1124\/jpet.110.170555_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.chembiol.2006.05.011","article-title":"Selective inhibition of c-Myc\/Max dimerization and DNA binding by small molecules","volume":"13","author":"Kiessling","year":"2006","journal-title":"Chem Biol"},{"key":"10.1124\/jpet.110.170555_bib21","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1073\/pnas.1332764100","article-title":"A global transcriptional regulatory role for c-Myc in Burkitt\u2019s lymphoma cells","volume":"100","author":"Li","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.110.170555_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/CAD.0b013e3280109424","article-title":"Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, down-regulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells","volume":"18","author":"Lin","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1124\/jpet.110.170555_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jsbmb.2006.09.028","article-title":"c-Myc overexpression and endocrine resistance in breast cancer","volume":"102","author":"McNeil","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/jpet.110.170555_bib24","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1073\/pnas.0601418103","article-title":"Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation","volume":"103","author":"Mo","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.110.170555_bib25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/jm801278g","article-title":"Discovery of novel myc-max heterodimer disruptors with a three-dimensional pharmacophore model","volume":"52","author":"Mustata","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.110.170555_bib26","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1038\/sj.onc.1202746","article-title":"MYC oncogenes and human neoplastic disease","volume":"18","author":"Nesbit","year":"1999","journal-title":"Oncogene"},{"key":"10.1124\/jpet.110.170555_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.1084","article-title":"p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin\u2019s lymphomas","volume":"67","author":"Pagnano","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1124\/jpet.110.170555_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(02)00738-9","article-title":"Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression","volume":"109","author":"Pelengaris","year":"2002","journal-title":"Cell"},{"key":"10.1124\/jpet.110.170555_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0010-468X(83)90082-X","article-title":"LAGRAN program for area and moments in pharmacokinetic analysis","volume":"16","author":"Rocci","year":"1983","journal-title":"Comput Programs Biomed"},{"key":"10.1124\/jpet.110.170555_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1124\/jpet.102.042952","article-title":"c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitor","volume":"304","author":"Russo","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.170555_bib31","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-07-2462","article-title":"MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells","volume":"67","author":"Sampson","year":"2007","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.110.170555_bib32","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1016\/j.bmcl.2009.09.044","article-title":"Small molecule inhibitors of Myc\/Max dimerization and Myc-induced cell transformation","volume":"19","author":"Shi","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.110.170555_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature07260","article-title":"Modelling Myc inhibition as a cancer therapy","volume":"455","author":"Soucek","year":"2008","journal-title":"Nature"},{"key":"10.1124\/jpet.110.170555_bib34","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/nar\/25.8.1493","article-title":"c-Myc\/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene","volume":"25","author":"Walhout","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/jpet.110.170555_bib35","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1158\/1535-7163.MCT-07-0005","article-title":"Improved low molecular weight Myc-Max inhibitors","volume":"6","author":"Wang","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.110.170555_bib36","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.onc.1210823","article-title":"c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle","volume":"27","author":"Wang","year":"2008","journal-title":"Oncogene"},{"key":"10.1124\/jpet.110.170555_bib37","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.bmc.2005.11.052","article-title":"A credit-card library approach for disrupting protein-protein interactions","volume":"14","author":"Xu","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.110.170555_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01066064","article-title":"A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation","volume":"6","author":"Yeh","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/jpet.110.170555_bib39","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1038\/sj.onc.1206641","article-title":"Low molecular weight inhibitors of Myc-Max interaction and function","volume":"22","author":"Yin","year":"2003","journal-title":"Oncogene"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524461405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524461405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.170555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:22:14Z","timestamp":1740018134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524461405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0022356524461405"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.170555","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc\/Max Dimerization","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.170555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}